drugset / Trial / NCT06814119
A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The goal of this study is to learn what happens to calderasib levels in a person's body over time. Researchers will measure what happens to calderasib levels in the body when it is given to people with moderate or severe renal impairment (RI) (meaning the kidneys do not work properly) as compared to people who are in good health. Researchers also want to learn about the safety of calderasib when it is given to people with RI and if people with RI can tolerate it.
Timeline
- Start
- 2025-04-07
- Primary completion
- 2026-01-23
- Completion
- 2026-02-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Calderasib | Unknown | — | Oral |